Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
09/29/1994 | CA2158546A1 Inhibition of selected tumor growth with recombinant viral vectors |
09/29/1994 | CA2158473A1 Dna, dna constructs, cells and plants derived therefrom |
09/29/1994 | CA2158461A1 Stimulation of immune response by viral protein |
09/29/1994 | CA2158429A1 Antibodies and assays for determining mutations in the apc gene |
09/29/1994 | CA2158428A1 Stromelysin-1 deficient transgenic mice |
09/29/1994 | CA2158364A1 Method for defined deletions of dna |
09/29/1994 | CA2158345A1 Cloned human alpha 1c adrenergic receptor |
09/29/1994 | CA2158252A1 Delivery system controlled through factors associated with hiv and cell |
09/29/1994 | CA2158148A1 Defective mutant non-retroviral virus (e.g. hsv) as vaccine |
09/29/1994 | CA2158145A1 An enzyme with pectin lyase activity |
09/29/1994 | CA2157596A1 T cell epitopes of ryegrass pollen allergen |
09/29/1994 | CA2157297A1 Novel pesticidal proteins and strains |
09/29/1994 | CA2156251A1 Expression of heterologous polypeptides in halobacteria |
09/29/1994 | CA2155739A1 Novel antimicrobial peptides from bovine neutrophils |
09/29/1994 | CA2155430A1 Method of controlling insects in plants using patatin gene expression |
09/29/1994 | CA2108548A1 Mutated form of the .beta.-amyloid precursor protein gene |
09/28/1994 | EP0617132A2 Probes and method to detect human immunodeficiency virus type 1 |
09/28/1994 | EP0617128A1 Recombinant vaccine for porcine pleuropneumonia |
09/28/1994 | EP0617127A1 Antigenic epitopes on B cell-bound IgE Immunoglobulins |
09/28/1994 | EP0617126A2 Polypeptide capable of inhibiting the binding bewteen human IL-6 and its receptor |
09/28/1994 | EP0617125A2 A novel transport protein gene from the Huntington's disease region |
09/28/1994 | EP0617124A1 Immune reactivity to expressed activated oncogenes for diagnosis and treatment of malignancy |
09/28/1994 | EP0617123A1 Kainate-binding, human CNS receptors of the EAA3 family |
09/28/1994 | EP0617122A1 Dna fragment which codes for tumor cell proliferation inhibiting factor |
09/28/1994 | EP0617047A1 Dye-labelled phosphoramadites |
09/28/1994 | EP0616645A1 Prohormone convertase transformed cells |
09/28/1994 | EP0616644A1 Fatty acid desaturase genes from plants |
09/28/1994 | EP0616643A1 Nucleotide sequences coding an endopolygalacturonase inhibitor |
09/28/1994 | EP0616641A1 Humanized b-b10, an anti-il2 receptor antibody |
09/28/1994 | EP0616640A1 Production of anti-self antibodies from antibody segment repertoires and displayed on phage |
09/28/1994 | EP0616639A1 Device and process for isolating and purifying nucleic acids |
09/28/1994 | EP0563255B1 Hpv39 papillomavirus genome-derived dna sequences, their application to in vitro diagnosis and production of immunogenic compositions |
09/28/1994 | EP0533906A4 Detection of dna/rna by fluorescence polarization |
09/28/1994 | EP0528925B1 New cloning and/or expression vectors, process for their preparation and use therof |
09/28/1994 | EP0528847B1 Soluble, truncated gamma-interferon receptors |
09/28/1994 | EP0506836B1 BCRF1 PROTEINS AS INHIBITORS OF INTERFERON-$g(g) |
09/28/1994 | EP0412964B1 Inhibition of htlv-iii by exogenous oligonucleotides |
09/28/1994 | EP0408742B1 Method for production and purification of hepatitis b vaccine |
09/28/1994 | EP0372063B1 Human myeloperoxydasis and its therapeutic application |
09/28/1994 | EP0222835B1 Oral vaccines |
09/28/1994 | CN1092812A Vaccines |
09/28/1994 | CN1026015C Recombinant DNA expression vectors and DNA compounds that encode deacetoxycephalosporinc synthetase and deacetylcephalosporinc synthetase |
09/27/1994 | US5350842 Diagnosis and prevention of syphilis |
09/27/1994 | US5350840 Diagnosis |
09/27/1994 | US5350836 Growth hormone antagonists |
09/27/1994 | US5350835 Cellular nucleic acid binding protein and uses thereof in regulating gene expression and in the treatment of aids |
09/27/1994 | US5350690 Sucrose inducible expression systems |
09/27/1994 | US5350689 Culture of plant cells |
09/27/1994 | US5350687 Antibodies which bind to novel lymphokine related peptides |
09/27/1994 | US5350683 DNA encoding type II interleukin-1 receptors |
09/27/1994 | US5350575 Infectious bursal disease virus in poultry |
09/26/1994 | CA2116640A1 Carcinoembryonic antigen derivatives |
09/24/1994 | CA2118675A1 Transport protein gene from the huntington's disease region |
09/24/1994 | CA2097254A1 Dna isolation method |
09/22/1994 | DE4308532A1 Monoclonal antibodies against in vivo glycated albumin |
09/21/1994 | EP0616035A2 Transgenic pathogen resistant organism |
09/21/1994 | EP0616034A2 Novel plasmid for production of CRM protein and diphtheria toxin |
09/21/1994 | EP0616033A1 Mutants of a thermostable neutral protease from Bacillus |
09/21/1994 | EP0616032A2 Preventive or therapeutic agents for Alzheimer's disease, a screening method for Alzheimer's disease, and human tau-protein kinase |
09/21/1994 | EP0615976A1 Method for monitoring pesticide resistance |
09/21/1994 | EP0615548A1 Novel proteases with dna fragmenting activity |
09/21/1994 | EP0615547A1 MAIZE ACETYL CoA CARBOXYLASE ENCODING DNA CLONES |
09/21/1994 | EP0615546A1 Region of cytoplasmic domain of the human interleukin-4 receptor, as antagonists of il-4 |
09/21/1994 | EP0615451A1 Novel cytokine that binds cd30 |
09/21/1994 | EP0404925B1 Method for transforming human b lymphocytes |
09/21/1994 | EP0371017B1 Antibodies against streptococcus |
09/21/1994 | CN1092525A Methods of detecting alzheimer's disease |
09/21/1994 | CN1092466A Gene of factor strenthening coding cell with large nucleus |
09/20/1994 | US5349128 Cucumber mosaic virus coat protein gene |
09/20/1994 | US5349127 Expression of herbicide metabolizing cytochromes P450 |
09/20/1994 | US5349126 Transforming with vector linked to DNA segment that encodes polypeptide with 3-hydroxy-3-methylglutaryl CoA reductase activity; insecticides |
09/20/1994 | US5349125 Flower pigmentation |
09/20/1994 | US5349124 Insect-resistant lettuce plants |
09/20/1994 | US5349123 Glycogen biosynthetic enzymes in plants |
09/20/1994 | US5349122 Use of lysozyme gene structures in plants to increase resistance |
09/20/1994 | US5349066 Bifunctional linking compounds, conjugates and methods for their production |
09/20/1994 | US5349059 Hybrid promoter contructs of glyceraldehyde-3-phosphate dehydrogenase promoter |
09/20/1994 | US5349058 Genetic engineering; DNA sequences |
09/20/1994 | US5349056 Modified ciliary neurotrophic factors |
09/20/1994 | US5349055 Genetic engineering |
09/20/1994 | US5348888 Genetic engineering |
09/20/1994 | US5348887 Vectors and DNAS for expression of a human adenocarcinoma antigen |
09/20/1994 | US5348886 Method of producing recombinant eukaryotic viruses in bacteria |
09/20/1994 | US5348881 Multiple bacteriocin producing lactococcus and compositions |
09/20/1994 | US5348876 DNA molecules and codes with polypeptide sequences |
09/20/1994 | US5348874 Eukaryotic transposable element |
09/20/1994 | US5348872 Method for isolating mutant cells |
09/20/1994 | US5348867 Expression of proteins on bacterial surface |
09/20/1994 | US5348866 Genes encoding porcine zona pellucida protein PZP-4, expression thereof and contraceptive vaccines comprising expressed (poly) peptides |
09/20/1994 | US5348865 Genome coding phytolacca antiviral protein and a recombinant expression vector therefor |
09/20/1994 | US5348864 Mouse vav proto-oncogene DNA and protein sequences |
09/20/1994 | US5348863 Process for the enzymatic preparation of basic fibroblast growth factor |
09/20/1994 | US5348858 Immunoassay by hybridomas |
09/20/1994 | US5348856 DNA encoding TRKC protein |
09/20/1994 | US5348743 Anti-pathogenically effective compositions comprising lytic peptides and hydrolytic enzymes |
09/20/1994 | US5348742 Anti-pathogenic bacterial strains of Pseudomonas fluorescens |
09/20/1994 | US5348741 Vector for recombinant poxvirus expressing rabies virus glycoprotein |
09/20/1994 | US5348740 Tapeworm |
09/20/1994 | CA1332049C Eukaryotic expression |
09/19/1994 | CA2119175A1 Nucleic acid pharmaceuticals |